Latest News

Fluorescent compounds allow clinicians to visualize Alzheimer's disease as it progresses

What if doctors could visualize all of the processes that take place in the brain during the development and progression of Alzheimer's disease? Such a window would provide a powerful aid for diagnosing the condition. Now, researchers have developed a new class of imaging agents that enables them to visualize tau protein aggregates, a pathological hallmark of Alzheimer's disease and related neurodegenerative disorders, directly in the brains of living patients.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Modified stem cells offer potential pathway to treat Alzheimer's disease

  • Scientists explain how memories stick together

  • In old age, lack of emotion, interest may signal brain is shrinking

  • Book early, after work if you want to enjoy your next hotel stay

  • Intravenously administered ketamine shown to reduce symptoms of chronic post-traumatic stress disorder

  • Distracted driving among teens threatens public health and safety

  • Conceptual representation in the brain: Towards mind-reading?

  • Common links between neurodegenerative diseases identified

  • For resetting circadian rhythms, neural cooperation is key

  • Neurons in brain tune into different frequencies for different spatial memory tasks

  •